Abstract
Superior mesenteric arteriovenous fistula is a rare vascular disorder. Endovascular embolization has been widely used to treat this disease. Patients receiving successful fistula embolization generally have good prognoses. We present a man with iatrogenic superior mesenteric arteriovenous fistula who received endovascular embolization. Portal thrombus was detected on postoperative day 2, and the patient eventually died of multiple organ failure on postoperative day 13 despite having received antithrombotic and antiplatelet therapy. We identified portal thrombosis as a serious complication of transcatheter superior mesenteric arteriovenous fistula embolization.
Copyright © 2014 Elsevier Inc. All rights reserved.
MeSH terms
-
Arteriovenous Fistula / diagnosis
-
Arteriovenous Fistula / etiology
-
Arteriovenous Fistula / therapy*
-
Embolization, Therapeutic / adverse effects*
-
Fatal Outcome
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Iatrogenic Disease*
-
Male
-
Mesenteric Artery, Superior* / diagnostic imaging
-
Mesenteric Artery, Superior* / injuries
-
Mesenteric Veins* / diagnostic imaging
-
Mesenteric Veins* / injuries
-
Middle Aged
-
Multiple Organ Failure / etiology
-
Phlebography / methods
-
Platelet Aggregation Inhibitors / therapeutic use
-
Portal Vein*
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Venous Thrombosis / diagnosis
-
Venous Thrombosis / drug therapy
-
Venous Thrombosis / etiology*
Substances
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors